Download PDFPDF
miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address